顔写真

PHOTO

Yamamoto Hiroyasu
山本 浩靖
Yamamoto Hiroyasu
山本 浩靖
Graduate School of Medicine Division of Health Sciences, Associate Professor

Research History 3

  1. 2017/04/01 - Present
    Osaka University Graduate School of Medicine Division of Health Sciences Associate Professor

  2. 2012/04/01 - 2017/03/31
    Osaka University Graduate School of Medicine Division of Health Sciences Assistant Professor

  3. 2012/03/01 - 2012/03/31
    Osaka University Graduate School of Medicine Division of Health Sciences Specially Appointed Researcher

Education 2

  1. Osaka University Graduate School, Division of Medical Sciences

    - 1999/03

  2. Osaka University Faculty of Medicine

    - 1992/03

Professional Memberships 8

  1. 日本内科学会

  2. 日本内分泌学会

  3. Endocrine Society

  4. 日本糖尿病学会

  5. 日本ステロイドホルモン学会

  6. 日本臨床検査医学会

  7. 日本動脈硬化学会

  8. 日本糖尿病合併症学会

Research Areas 2

  1. Life sciences / Metabolism and endocrinology /

  2. Life sciences / Cardiology /

Papers 52

  1. Anti-apo b-100 autoantibody is a marker of unstable coronary plaque

    Minami Imai, Mari Kawamura, Ikoi Kochi, Tetsuro Matsuoka, Shinji Kihara, Hiroyasu Yamamoto

    Journal of Atherosclerosis and Thrombosis Vol. 28 No. 10 p. 1025-1034 2021/10/01 Research paper (scientific journal)

    Publisher: Japan Atherosclerosis Society
  2. Serum Anti-Apo B Antibody Level as Residual CVD Marker in DM Patients under Statin Treatment.

    Yamamoto H, Kawamura M, Kochi I, Imai M, Murata Y, Suzuki T, Chen Y, Hashimoto K, Kihara S

    Journal of Atherosclerosis and Thrombosis Vol. 26 No. 10 p. 931-943 2019/10 Research paper (scientific journal)

  3. Juvenile-onset systemic lupus erythematosus with severe hypertriglyceridemia induced by anti-apolipoprotein C-II antibody.

    Inoue M, Kawamura M, Yamamoto H, Takahashi T, Kihara S

    Pediatrics International Vol. 61 No. 2 p. 201-203 2019/02 Research paper (scientific journal)

  4. Marked elevation of serum M2BP-adiponectin complex in men with coronary artery disease.

    Niinaga R, Yamamoto H, Yoshii M, Uekita H, Yamane N, Kochi I, Matsumoto A, Matsuoka T, Kihara S

    Atherosclerosis 2016/08 Research paper (scientific journal)

  5. E-selectin ligand-1 (ESL-1) is a novel adiponectin binding protein on cell adhesion.

    Yamamoto H, Kuroda N, Uekita H, Kochi I, Matsumoto A, Niinaga R, Funahashi T, Shimomura I, Kihara S

    Biochemical and Biophysical Research Communications 2016/02 Research paper (scientific journal)

  6. Impact of Remnant Lipoprotein on Coronary Plaque Components

    Natsumi Matsuo, Tetsuro Matsuoka, Sumire Onishi, Hiroyasu Yamamoto, Akinobu Kato, Yasunaka Makino, Shinji Kihara

    J Atheroscler Thromb 2015/08 Research paper (scientific journal)

  7. SIRT2 deficiency modulates macrophage polarization and susceptibility to experimental colitis.

    Lo Sasso G, Menzies KJ, Mottis A, Piersigilli A, Perino A, Yamamoto H, Schoonjans K, Auwerx J

    PLos One Vol. 9 No. 7 2014/07 Research paper (scientific journal)

  8. Autoimmune severe hypertriglyceridemia induced by anti-apolipoprotein C-II antibody

    Hiroyasu Yamamoto, Minoru Tanaka, Satomi Yoshiga, Tohru Funahashi, Iichiro Shimomura, Shinji Kihara

    Journal of Clinical Endocrinology and Metabolism Vol. 99 No. 5 p. 1525-1530 2014 Research paper (scientific journal)

    Publisher: Endocrine Society
  9. Novel combined GPIHBP1 mutations in a patient with hypertriglyceridemia associated with CAD

    Hiroyasu Yamamoto, Misa Onishi, Naoko Miyamoto, Ryosuke Oki, Hiroyasu Ueda, Masato Ishigami, Hisatoyo Hiraoka, Yuji Matsuzawa, Shinji Kihara

    Journal of Atherosclerosis and Thrombosis Vol. 20 No. 10 p. 777-784 2013 Research paper (scientific journal)

  10. LRH-1-dependent glucose sensing determines intermediary metabolism in liver.

    Oosterveer MH, Mataki C, Yamamoto H, Harach T, Moullan N, van Dijk TH, Ayuso E, Bosch F, Postic C, Groen AK, Auwerx J, Schoonjans K

    Journal of Clinical Investigation Vol. 122 No. 8 p. 2817-2826 2012/08 Research paper (scientific journal)

  11. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity.

    Cantó C, Houtkooper RH, Pirinen E, Youn DY, Oosterveer MH, Cen Y, Fernandez-Marcos PJ, Yamamoto H, Andreux PA, Cettour-Rose P, Gademann K, Rinsch C, Schoonjans K, Sauve AA, Auwerx J

    Cell Metabolism Vol. 15 No. 6 p. 838-847 2012/06 Research paper (scientific journal)

  12. Muscle or liver-specific Sirt3 deficiency induces hyperacetylation of mitochondrial proteins without affecting global metabolic homeostasis.

    Fernandez-Marcos PJ, Jeninga EH, Canto C, Harach T, de Boer VC, Andreux P, Moullan N, Pirinen E, Yamamoto H, Houten SM, Schoonjans K, Auwerx J

    Sci Rep Vol. 2 2012/05 Research paper (scientific journal)

  13. NCoR1 is a conserved physiological modulator of muscle mass and oxidative function.

    Yamamoto H, Williams EG, Mouchiroud L, Cantó C, Fan W, Downes M, Héligon C, Barish GD, Desvergne B, Evans RM, Schoonjans K, Auwerx J

    Cell Vol. 147 No. 4 p. 827-839 2011/11 Research paper (scientific journal)

  14. Adipocyte NCoR knockout decreases PPARγ phosphorylation and enhances PPARγ activity and insulin sensitivity.

    Li P, Fan W, Xu J, Lu M, Yamamoto H, Auwerx J, Sears DD, Talukdar S, Oh D, Chen A, Bandyopadhyay G, Scadeng M, Ofrecio JM, Nalbandian S, Olefsky JM

    Cell Vol. 147 No. 4 p. 815-826 2011/11 Research paper (scientific journal)

  15. Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling.

    Beirowski B, Gustin J, Armour SM, Yamamoto H, Viader A, North BJ, Michán S, Baloh RH, Golden JP, Schmidt RE, Sinclair DA, Auwerx J, Milbrandt J

    Proc Natl Acad Sci U S A. Vol. 108 No. 43 p. E952-E961 2011/10 Research paper (scientific journal)

  16. CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability

    NORIEGA LG

    EMBO Rep Vol. 12 No. 10 p. 1069-1076 2011/09 Research paper (scientific journal)

  17. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation.

    Bai P, Cantó C, Oudart H, Brunyánszki A, Cen Y, Thomas C, Yamamoto H, Huber A, Kiss B, Houtkooper RH, Schoonjans K, Schreiber V, Sauve AA, Menissier-de Murcia J, Auwerx J

    Cell Metabolism Vol. 13 No. 4 p. 461-468 2011/04 Research paper (scientific journal)

  18. PARP-2 regulates SIRT1 expression and whole-body energy expenditure.

    Bai P, Canto C, Brunyánszki A, Huber A, Szántó M, Cen Y, Yamamoto H, Houten SM, Kiss B, Oudart H, Gergely P, Menissier-de Murcia J, Schreiber V, Sauve AA, Auwerx J

    Cell Metabolism Vol. 13 No. 4 p. 450-460 2011/04 Research paper (scientific journal)

  19. SIRT1 mRNA expression may be associated with energy expenditure and insulin sensitivity

    RUTANEN J

    Diabetes Vol. 59 No. 4 p. 829-835 2010/04 Research paper (scientific journal)

  20. Effects of Pitavastatin on Serum Lipids and High Sensitivity C-Reactive Protein in Type 2 Diabetic Patients

    MOTOMURA Takashi, OKAMOTO Maki, KITAMURA Tetsuhiro, YAMAMOTO Hiroyasu, OTSUKI Michio, ASANUMA Nobuyuki, TAKAGI Miki, KUREBAYASHI Shogo, HASHIMOTO Kunihiko, SUMITANI Satoru, SAITO Hiroshi, KOUHARA Haruhiko, NISHII Kazumasa, NAKAO Makoto, KOGA Masafumi, SATO Bunzo, MORIMOTO Yasuhiko, KASAYAMA Soji

    Vol. 16 No. 5 p. 546-552 2009/10 Research paper (scientific journal)

  21. TGR5-mediated bile acid sensing controls glucose homeostasis

    THOMAS C

    Cell Metab Vol. 10 No. 3 p. 167-177 2009/09 Research paper (scientific journal)

  22. CXC ligand 5 is an adipose-tissue derived factor that links obesity to insulin resistance

    CHAVEY C

    Cell Metab Vol. 9 No. 4 p. 339-349 2009/04 Research paper (scientific journal)

  23. グリメピリド長期投与2型糖尿病患者の臨床的特徴

    大月道夫, 笠山宗正, 幸原晴彦, 斉藤博, 住谷哲, 山本浩靖, 稲葉真紀子, 下村伊一郎

    新薬と臨床 Vol. 58 p. 94-100 2009/01 Research paper (scientific journal)

  24. Asthma is an independent risk for elevation of plasma C-reactive protein levels.

    Kasayama S, Tanemura M, Koga M, Fujita K, Yamamoto H, Miyatake A

    Clin Chim Acta Vol. 399 No. 1-2 p. 79-82 2009/01 Research paper (scientific journal)

  25. A novel growth hormone receptor gene deletion mutation in a patient with primary growth hormone insensitivity syndrome (Laron syndrome).

    Yamamoto H, Kouhara H, Iida K, Chihara K, Kasayama S

    Growth Horm IGF Res. Vol. 18 No. 2 p. 136-142 2008/04 Research paper (scientific journal)

  26. Sirtuin functions in health and disease.

    Yamamoto H, Schoonjans K, Auwerx J

    Molecular Endocrinology Vol. 21 No. 8 p. 1745-1755 2007/08

  27. Impacts of long-term treatments with testosterone replacement and pioglitazone on glucose and lipid metabolism in male patients with Werner's syndrome.

    Yamamoto H, Kurebayashi S, Kouhara H, Yoshiuchi K, Matsuhisa M, Yamasaki Y, Kasayama S

    Clin Chim Acta Vol. 379 No. 1-2 p. 167-170 2007/04 Research paper (scientific journal)

  28. The thiazolidinedione drug troglitazone up-regulates nitric oxide synthase expression in vascular endothelial cells.

    Goya K, Sumitani S, Otsuki M, Xu X, Yamamoto H, Kurebayashi S, Saito H, Kouhara H, Kasayama S

    J Diabetes Complications. Vol. 20 No. 5 p. 336-342 2006/09 Research paper (scientific journal)

  29. Improvement of Reduced Bone Mineral Density by Intermittent Cyclical Etidronate in Postmenopausal Asthmatic Patients Receiving Inhaled Corticosteroids.

    Yamamoto H, Kasayama S, Fujita M, Fujita K, Morimoto Y, Kawase I, Miyatake A

    Allergology International Vol. 54 p. 137-141 2005/09 Research paper (scientific journal)

  30. Effects of alendronate on bone mineral density and bone metabolic markers in postmenopausal asthmatic women treated with inhaled corticosteroids.

    Kasayama S, Fujita M, Goya K, Yamamoto H, Fujita K, Morimoto Y, Kawase I, Miyatake A

    Metabolism Vol. 54 No. 1 p. 85-90 2005/01 Research paper (scientific journal)

  31. Strong association of C-reactive protein with body mass index and 2-h post-challenge glucose in non-diabetic, non-smoker subjects without hypertension

    HASHIMOTO K

    Diabet Med Vol. 21 No. 6 p. 581-585 2004/06 Research paper (scientific journal)

  32. Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells.

    Goya K, Sumitani S, Xu X, Kitamura T, Yamamoto H, Kurebayashi S, Saito H, Kouhara H, Kasayama S, Kawase I

    Arterioscler Thromb Vasc Biol. Vol. 24 No. 4 p. 658-663 2004/04 Research paper (scientific journal)

  33. Runx2 deficiency in chondrocytes causes adipogenic changes in vitro

    ENOMOTO H.

    J. Cell Sci. Vol. 117 No. 3 p. 417-425 2004/01 Research paper (scientific journal)

  34. Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members.

    Ruddy MJ, Wong GC, Liu XK, Yamamoto H, Kasayama S, Kirkwood KL, Gaffen SL

    Journal of Biological Chemistry Vol. 279 No. 4 p. 2559-2567 2004/01 Research paper (scientific journal)

  35. Risk factors for asymptomatic atherosclerosis in Japanese type 2 diabetic patients without diabetic microvascular complications.

    Goya K, Kitamura T, Inaba M, Otsuki M, Yamamoto H, Kurebayashi S, Sumitani S, Saito H, Kouhara H, Kasayama S, Kawase I

    Metabolism Vol. 52 No. 10 p. 1302-1306 2003/10 Research paper (scientific journal)

  36. Adipose-specific expression, phosphorylation of Ser794 in insulin receptor substrate-1, and activation in diabetic animals of salt-inducible kinase-2.

    Horike N, Takemori H, Katoh Y, Doi J, Min L, Asano T, Sun XJ, Yamamoto H, Kasayama S, Muraoka M, Nonaka Y, Okamoto M

    Journal of Biological Chemistry Vol. 278 No. 29 p. 18440-18447 2003/05 Research paper (scientific journal)

  37. 糖尿病患者にみられる神経障害の自覚症状の特徴

    山本浩靖, 大月道夫, 高木美紀, 西井一雅, 森本靖彦, 三木俊治, 佐藤文三, 笠山宗正

    新薬と臨床 Vol. 52 p. 138-144 2003/01 Research paper (scientific journal)

  38. Acromegaly患者における耐糖能障害に及ぼす手術療法と薬物療法の効果

    山本浩靖, 笠山宗正

    第1回関西間脳下垂体研究会記録集 Vol. 1 p. 4-5 2003/01

  39. Reduced IRS-2 and GLUT4 expression in PPARgamma2-induced adipocytes derived from C/EBPbeta and C/EBPdelta-deficient mouse embryonic fibroblasts.

    Yamamoto H, Kurebayashi S, Hirose T, Kouhara H, Kasayama S

    Journal of Cell Science Vol. 115 No. 18 p. 3601-3607 2002/09 Research paper (scientific journal)

  40. Hepatoma-derived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals

    KISHIMA Y

    J Biol Chem Vol. 277 No. 12 p. 10315-10322 2002/03 Research paper (scientific journal)

  41. Characterization of premature atherosclerosis of carotid arteries in acromegalic patients.

    Otsuki M, Kasayama S, Yamamoto H, Saito H, Sumitani S, Kouhara H, Saitoh Y, Ohnishi T, Arita N

    Clinical Endocrinology Vol. 54 No. 6 p. 791-796 2001/06 Research paper (scientific journal)

  42. 下垂体前葉機能低下症と尿崩症を合併し、術後に下垂体前葉機能のみ回復を認めた下垂体膿瘍の1例

    古川貢, 山本浩靖, 幸原晴彦, 羽柴哲夫, 稲垣昌士, 大西丘倫, 笠山宗正

    ホルモンと臨床 Vol. 49 p. 14-18 2001/01 Research paper (scientific journal)

  43. PPARα and GR differentially down-regulate the expression of nuclear factor-κB-responsive genes in vascular endothelial cells

    Xin Xu, Michio Otsuki, Hiroshi Saito, Satoru Sumitani, Hiroyasu Yamamoto, Nobuyuki Asanuma, Haruhiko Kouhara, Soji Kasayama

    Endocrinology Vol. 142 No. 8 p. 3332-3339 2001 Research paper (scientific journal)

    Publisher: Endocrine Society
  44. ペン型インスリン注入器ヒューマペンエルゴを用いたインスリン導入が2型糖尿病患者のインスリン治療イメージに与える影響

    高木美紀, 元村卓嗣, 西井一雅, 山本浩靖, 大月道夫, 住谷哲, 幸原晴彦, 笠山宗正

    新薬と臨床 Vol. 49 p. 1049-1054 2000/01 Research paper (scientific journal)

  45. 脂肪細胞分化に伴うGLUT4発現におけるC/EBP-β、-δの役割-C/EBP-β、-δ欠損マウス由来繊維芽細胞を用いた解析-

    山本浩靖, 紅林昌吾, 住谷哲, 弘世貴久, 住谷哲, 幸原晴彦, 笠山宗正

    Diabetes Frontier Vol. 11 2000/01

  46. 脂肪細胞の分化は、C/EBP-β、-δ 非存在下でもPPAR-γ2の強制発現にて誘導し得る

    山本浩靖, 紅林昌吾, 住谷哲, 弘世貴久, 幸原晴彦, 笠山宗正, 岸本忠三

    分子糖尿病学 Vol. 10 p. 41-45 1999/01 Research paper (scientific journal)

  47. PPAR- γ2によるマウス胎児由来線維芽細胞の脂肪細胞への分化

    山本浩靖, 紅林昌吾, 弘世貴久, 住谷哲, 幸原晴彦, 笠山宗正

    ホルモンと臨床 Vol. 47 p. 63-67 1999/01 Research paper (scientific journal)

  48. NF-kappaB activation in CD27 signaling: involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27.

    Yamamoto H, Kishimoto T, Minamoto S

    Journal of Immunology Vol. 161 No. 9 p. 4753-4759 1998/11 Research paper (scientific journal)

  49. Cloning and Functional Analysis of New Members of STAT Induced STAT Inhibitor (SSI) Family: SSI-2 and SSI-3

    Seijiro Minamoto, Kazuhiro Ikegame, Kiyonobu Ueno, Masashi Narazaki, Tetsuji Naka, Hiroyasu Yamamoto, Tomoshige Matsumoto, Hiroshi Saito, Shigeto Hosoe, Tadamitsu Kishimoto

    Biochemical and Biophysical Research Communications Vol. 237 No. 1 p. 79-83 1997/08 Research paper (scientific journal)

    Publisher: Elsevier BV
  50. A Patient with Acromegaly Who Showed Remarkable Improvement of Hyperglycemia after Treatment with Octreotide

    HIROSE Takahisa, KURODA Tadashi, OTSUKI Michio, TAKAGI Miki, YAMAMOTO Hiroyasu, MOTOMURA Takashi, KUREBAYASHI Shogo, MIYASHITA Yoshihiro, KOGA Masafumi, ARITA Norio, HAYAKAWA Toru, KISHIMOTO Tadamitsu, KASAYAMA Soji

    Japanese Journal of Medicine Vol. 36 No. 5 p. 345-350 1997/05 Research paper (scientific journal)

    Publisher: The Japanese Society of Internal Medicine
  51. Advanced glycation end products stimulate interleukin-6 production by human bone-derived cells

    TAKAGI M

    J Bone Miner Res Vol. 12 No. 3 p. 439-446 1997/03 Research paper (scientific journal)

  52. 原発性無月経を呈した46X, pseu dic (X)(pter→q25: q25→pter) の1症例

    山本浩靖, 幸原晴彦, 中尾皖英, 橋本久仁彦, 宮下義博, 笠山宗正, 古賀正史, 佐藤文三, 岸本忠三

    ホルモンと臨床 Vol. 43 p. 272-275 1995/01 Research paper (scientific journal)

Publications 6

  1. Novel combined GPIHBP1 mutaions in a patient with hypertriglyceridemia associated with CAD

    Hiroyasu YAMAMOTO, Shinji KIHARA

    2015/08 Scholarly book

    ISBN: 9784779215162

  2. Annual Review 糖尿病・代謝・内分泌 2015 : 自己免疫機序による脂質異常症

    山本浩靖, 木原進士

    中外医学社 2015/01 Scholarly book

    ISBN: 4498123530

  3. オートファジーと疾患/プログレッシブ 生命科学(第1版)

    吉森 保

    南山堂 2014/09 Textbook, survey, introduction

    ISBN: 9784525134310

  4. NR Coregulators and Human Diseases: Chapter 9: Coregulators in Metabolic and Neurodegenerative Diseases.

    Feige JN, Yamamoto H, Auwerx J

    World Scientific Publishing Co Pte Ltd 2008/03 Scholarly book

    ISBN: 9789812705365

  5. 内分泌代謝疾患・糖尿病診療マニュアル:骨粗鬆症の治療

    山本浩靖

    医薬ジャーナル社 2002/04 Scholarly book

    ISBN: 9784753219865

  6. 内分泌代謝疾患・糖尿病診療マニュアル:骨粗鬆症の診断

    山本浩靖

    医薬ジャーナル社 2002/04 Scholarly book

    ISBN: 4753219860

Institutional Repository 1

Content Published in the University of Osaka Institutional Repository (OUKA)
  1. NF-κB Activation in CD27 Signaling : Involvement of TNF Receptor-Associated Factors (TRAFs) in Its Signaling and Identification of Functional Region of CD27

    山本 浩靖